This stock needs NEW sponsorship. So far, Morgan Joseph's call hasn't been followed. Yesterday, the stock had a distribution day, one day after a low volume rise after the analyst upgrade. We have had a few upgrades over the past few months...both with $20-21 targets. We had solid earnings and guidance in an AWFUL medical technology/products market given weak hospital budgets and the healthcare bill uncertainty.
We need some insider buying, a stock buyback, new product launches, new partnerships or an acquisition by Boston Scientific...what are they waiting for? BSI is losing 80% of the head-to-head deals for IVUS against VOLC and the FFR product is growing 50%+ and only competes with STJ, which Medtronic competes with everday.
Time for Medtronic to buy VOLC for $22.50 per share.